Axumin for functional imaging of prostate cancer recurrence

  • Medtech innovation briefing
  • MIB172
  • Published: 
Download (PDF)

Regulatory information

Axumin was regulated for use in the EU on 22 May 2017 by the European Medicine Agency's Committee for Medicinal Products for Human Use.